<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>21</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2022</Year>
        <Month>08</Month>
        <Day>12</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of T Cell Proliferation Using CFSE Dilution Assay: A Comparison between Stimulation with PHA and Anti-CD3/Anti-CD28 Coated Beads</title>
    <FirstPage>458</FirstPage>
    <LastPage>466</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Kashef</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mozhgan</FirstName>
        <LastName>Moghtaderi</LastName>
        <affiliation locale="en_US">Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Hatami</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Kalani</LastName>
        <affiliation locale="en_US">Prof. Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Soheila</FirstName>
        <LastName>Alyasin</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Shiraz University of Medical Sciences, Shiraz, Iran  AND Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hesamodin</FirstName>
        <LastName>Nabavizadeh</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Shiraz University of Medical Sciences, Shiraz, Iran AND Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Ira</affiliation>
      </Author>
      <Author>
        <FirstName>Shirin</FirstName>
        <LastName>Farjadian</LastName>
        <affiliation locale="en_US">Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>02</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">A decrease in T cell count or reduced T cell function can be indicative of T cell immunodeficiency. In the present study, T-cell function was assessed using Carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution test after stimulation with commonly used Phytohaemagglutinin (PHA) or anti-CD3/anti-CD28 coated beads in pediatric patients with recurrent infections.
Seven infants with recurrent infections and seven sex/age-matched healthy infants were included in this study. A blood cell count, immunophenotyping, and serum immunoglobulin level were performed. The proliferation of T cells was also assessed with CFSE dilution after stimulation with PHA or anti-CD3/anti-CD28 coated beads.&#xA0;
This study showed increased IgA, IgG, and IgM levels in patients compared to the controls. In contrast to the controls, the immunophenotyping results showed a significant decline in the number of CD4+ T cells in patients. Although there was no difference in CD3+ T cell proliferation between patients and controls, the CD4+ and CD8+ T cell proliferation rates were significantly decreased in patients when stimulated with PHA.
As a mitogen with the potential for maximum proliferation of T cells, PHA is better able to distinguish between patients with recurrent infections and controls than anti-CD3/anti-CD28, which mimics only the TCR pathway for stimulation of T cells.&#xA0;</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3311</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/3311/1875</pdf_url>
  </Article>
</Articles>
